Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
Bruna Gigante, Senior Consultant at Karolinska University Hospital, Associate Professor of Epidemiology at Karolinska Institutet, shared EHC – European Haemophilia Consortium’s post on LinkedIn:
“What a wonderful way to celebrate World Heart Day!
Being invited in a round table at the European Parliament to discuss treatment of Cardiovascular disease in people living with bleeding disorders.
When the heart meets the blood! Congratulations to the organizers and to the participants.”
EHC – European Haemophilia Consortium shared a post on LinkedIn:
“Today, the EHC brought patients, clinicians and policymakers together at the European Parliament in Brussels for a Round Table on ‘Bridging the Gap: Bleeding Disorders and Cardiovascular Care in Europe’, hosted by MEP Aurelijus Veryga.
The central question: how do we protect the hearts of people who live with a bleeding disorder?
Key takeaways from the discussion:
- Bleeding disorders don’t protect against cardiovascular disease, so heart health needs to be part of routine bleeding disorder care.
- People with bleeding disorders can need lifelong antithrombotic treatment for heart disease. Because thrombosis and bleeding risk change over time, treatment must be re-evaluated and patients need to be aware of the risks.
- Haematologists and cardiologists need to coordinate closely, and lived experience shows what this means in practice.
Clear guidance and EU policy attention can help make cardiovascular care for people with bleeding disorders consistent and coordinated across Europe, through more clinical data and standardised guidelines.
Thank you to MEP Aurelijus Veryga, EHC President Tatjana Markovic, Dr Bruna Gigante, EHC Vice-President Dr William McKeown, patient advocate Miguel Crato, and to everyone who joined!”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines